ArticleJournal of Cancer2021

miR-369 inhibits Liver Cancer progression by targeting ZEB1 pathway and predicts the prognosis of HCC patients.

Yuwei Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.